- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
research use only
Cat.No.S7931
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| A2780 cells | Function assay | 48 h | Inhibition of NAMPT in human A2780 cells assessed as reduction in NAD level after 48 hrs by LC-MS/MS analysis, IC50=0.024 μM | |||
| RCC4 cells | Cytotoxicity assay | 4 days | Cytotoxicity against human RCC4 cells after 4 days by XTT assay, IC50=0.16 μM | |||
| HT1080 cells | Proliferation assay | 96 h | Antiproliferative activity against human HT1080 cells after 96 hrs by CyQuant-based assay, IC50=0.213 μM | |||
| PC3 cells | Proliferation assay | 96 h | Antiproliferative activity against human PC3 cells after 96 hrs by CyQuant-based assay, IC50=0.217 μM | |||
| HCT116 cells | Proliferation assay | 96 h | Antiproliferative activity against human HCT116 cells after 96 hrs by CyQuant-based assay, IC50=0.271 μM | |||
| MIAPaCa2 cells | Proliferation assay | 96 h | Antiproliferative activity against human MIAPaCa2 cells after 96 hrs by CyQuant-based assay, IC50=0.855 μM | |||
| Click to View More Cell Line Experimental Data | ||||||
|
In vitro |
DMSO
: 85 mg/mL
(200.69 mM)
Ethanol : 25 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 423.53 | Formula | C23H25N3O3S |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 724741-75-7 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NCC2=CC=C(C=C2)C(=O)NC3=CN=CC=C3 | ||
| Targets/IC50/Ki |
GLUT1
|
|---|---|
| In vitro |
STF-31 selectively kills RCCs by specifically targeting glucose uptake through GLUT1. This compound significantly inhibits lactate production and extracellular acidification in VHL-deficient cells by about 60%, and decreases glycolysis by decreasing glucose transport. In NAPRT1-expressing cells, it shows cytotoxicity by inhibiting the enzymatic activity of NAMPT. It is toxic to hPSCs and efficient for selective elimination of hPSCs from mixed cultures.
|
| In vivo |
In mice with VHL-deficient RCC xenografts, a more soluble analog of STF-31 (11.6 mg/kg, i.p.) markedly delays tumor growth.
|
References |
|
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Western blot | TFCP2 / ASIC2a p-EGFR / HIF-1α / c-Myc / Glut-1 |
|
28725010 |
| Immunofluorescence | ASIC2a / TFCP2 |
|
28725010 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.